Enaleni Pharmaceuticals Limited - Dealing in secur
ENL
ENL
Enaleni Pharmaceuticals Limited - Dealing in securities by directors
Enaleni Pharmaceuticals Limited
(Incorporated in the Republic of South Africa)
(Registration number 2002/018027/06)
(JSE code: ENL & ISIN: ZAE000067740)
("Enaleni")
DEALING IN SECURITIES BY DIRECTORS
In terms of paragraph 3.63 - 3.65 of the JSE Limited Listings Requirements, the
following information, relating to the sale of ordinary shares on the open
market by Chris Aucamp, an executive director of Cipla Medpro, a major
subsidiary of Enaleni, is disclosed as follows:
Date of transaction: 02 May 2006
Number of shares: 120 000
Price: 435 cents per share
Value of transaction: R522 000,00
Date of transaction: 03 May 2006
Number of shares: 69 000
Price: 433,84 cents per share
Value of transaction: R299 349,60
Extent of interest: Indirect non-beneficial
Written clearance to
deal obtained: Yes
Johannesburg
4 May 2006
Sponsor
Nedbank Capital
Date: 04/05/2006 04:30:04 PM Produced by the JSE SENS Department
Profile Group (Pty) Ltd. has taken care in preparing all information on this website, but does not accept any liability for errors or out-of-date information.
